Sort
82,697 grants matching “vaccine development”
Pitt-Ohio State Clinical Trials Unit
$2,344,903John W Mellors · University Of Pittsburgh At Pittsburgh · UM1 · FY2021 · AI
SPORE in Lymphoma
$2,344,258Helen E Heslop · Baylor College Of Medicine · P50 · FY2016 · CA
Systems Epigenomics of Persistent Bloodstream Infection
$2,344,235Michael R Yeaman · Lundquist Institute For Biomedical Innovation At Harbor-Ucla Medical Center · U19 · FY2024 · AI
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,344,199Dartmouth College · P20 · FY2003 · RR
IMMUNE MECHANISMS CONTROLLING INFLAMMATION AND CANCER
$2,343,963Dartmouth College · P20 · FY2004 · RR
Anti-viral immune responses in lymph node
$2,343,698Ulrich H Von Andrian · Harvard Medical School · P01 · FY2009 · AI
Acute HIV Infection: Implications for vaccine design
$2,343,422Marcus Altfeld · Massachusetts General Hospital · P01 · FY2009 · AI
Resource Support Program for AIDS Vaccine Development
$2,343,420Quality Biological, Inc. · N01 · FY2025 · AI
Optimizing the immunogenicity of next generation polyvalent HIV vaccine formulati
$2,343,029Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2013 · AI
Genetic approaches to discover host factors critical to dengue virus infection
$2,342,634Jan E Carette · Stanford University · DP2 · FY2012 · AI
Adverse Cerebrovascular Responses to Antibodies Targeting Beta-Amyloid
$2,342,415David Hastings Cribbs · University Of California-Irvine · RF1 · FY2024 · NS
Collision of Alzheimers disease and COVID-19 pandemic in the United States: risks, outcomes, disparities and treatments
$2,342,002Rong Xu · Case Western Reserve University · RF1 · FY2022 · AG
Genetics, Pathophysiology, and Treatment of Recessive Autoinflammatory Diseases
$2,341,702Daniel Kastner · National Human Genome Research Institute · ZIA · FY2022 · HG
Vaccine and Monoclonal Antibody Studies in HIV-infected Subjects
$2,341,505Julie E. Ledgerwood · National Institute Of Allergy And Infectious Diseases · ZIA · FY2018 · AI
Advancing Transplantation Outcomes in Children
$2,341,354David Michael Briscoe · Boston Children'S Hospital · U01 · FY2021 · AI
Center for Cancer Immunology and Immunotherapy (CCII)
$2,337,631Jun Yan · University Of Louisville · P20 · FY2020 · GM
PATIENT SAFETY MONITORING IN INTERNATIONAL LABORATORIES (SMILE)
$2,337,157Robert Miller · Johns Hopkins University · N01 · FY2016 · AI
Maternal and infant immunization to eliminate breast milk transmission of HIV-1
$2,336,538Sallie R. Permar · Duke University · P01 · FY2018 · AI
Prevention and therapy of Staphylococcus aureus infections
$2,335,143Olaf Schneewind · University Of Chicago · RC4 · FY2010 · AI
A Global Syphilis Vaccine Targeting Outer Membrane Proteins of Treponema pallidum.
$2,334,857Justin D. Radolf · University Of Connecticut Sch Of Med/Dnt · U19 · FY2019 · AI
Innate and Adaptive Immune Responses in SARS-CoV-2 infection (COVID-19)
$2,333,309Daniel Cesar Douek · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
The intersection of innate and adaptive immunity to intracellular pathogens
$2,333,166Daniel A Portnoy · University Of California Berkeley · P01 · FY2022 · AI
High-Resolution Inference for Correlates of Vaccine Protection
$2,332,500Alex Luedtke · University Of Washington · DP2 · FY2019 · LM
Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer
$2,332,307Chad A. Mirkin · Northwestern University At Chicago · U54 · FY2015 · CA
Radiation Survivor Core
$2,331,858J. Mark Cline · Duke University · U19 · FY2015 · AI